1) Celebrex 2) Cox-2 inhibitor 3) Pfizer product 1) Celebrex 
After the withdrawal of rofecoxib from the market in September 2004, Celebrex enjoyed a robust increase in sales. However, the results of the APC trial in December of that year raised concerns that Celebrex might carry risks similar to those of rofecoxib, and Pfizer announced a moratorium on direct-to-consumer advertising of Celebrex soon afterwar...
A drug that reduces pain. Celecoxib belongs to the family of drugs called nonsteroidal anti-inflammatory agents. It is being studied in the prevention of cancer.
(sel″ә-kok´sib) a nonsteroidal antiinflammatory drug of the cox-2 inhibitors group, administered orally for symptomatic treatment of arthritis.
[n] - a Cox-2 inhibitor (trade name Celebrex) that relieves pain without harming the digestive tract
Celebrex noun a Cox-2 inhibitor (trade name Celebrex) that relieves pain without harming the digestive tract